Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era-Reference-Cited by-同舟云学术

Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era

Published:2016-12-28 Issue:1 Volume:19 Page:e12630
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Olarte Liset¹,Lin Philana Ling²,Barson William J.³,Romero Jose R.⁴,Tan Tina Q.⁵,Givner Laurence B.⁶,Hoffman Jill A.⁷,Bradley John S.⁸,Hultén Kristina G.¹,Mason Edward O.¹,Kaplan Sheldon L.¹

Affiliation:

1. Department of Pediatrics; Baylor College of Medicine; Houston TX USA

2. Department of Pediatrics; Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center; Pittsburgh PA USA

3. Department of Pediatrics; Ohio State University College of Medicine; Columbus OH USA

4. Department of Pediatrics; University of Arkansas for Medical Sciences; Little Rock AR USA

5. Department of Pediatrics; Northwestern University Feinberg School of Medicine; Chicago IL USA

6. Department of Pediatrics; Wake Forest School of Medicine; Winston-Salem NC USA

7. Department of Pediatrics; University of Southern California School of Medicine; Los Angeles CA USA

8. Department of Pediatrics; Rady Children's Hospital San Diego; San Diego CA USA

Funder

Pfizer

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12630/fullpdf

Reference30 articles.

1. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host;Rubin;Clin Infect Dis,2014

2. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP);Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2013

3. Invasive pneumococcal disease in pediatric organ transplant recipients: A high-risk population;Tran;Pediatr Transplant,2005

4. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine;Kaplan;Pediatrics,2004

5. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine;Kaplan;Pediatr Infect Dis J,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine schedule recommendations and updates for patients with hematologic malignancy post‐hematopoietic cell transplant or CAR T‐cell therapy;Transplant Infectious Disease;2023-07-29

2. A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM);Clinical Infectious Diseases;2023-06-20

3. SPILF update on bacterial arthritis in adults and children;Infectious Diseases Now;2023-06

4. Survey of pediatric transplant center practices regarding COVID‐19 vaccine mandates for transplant candidates and living donors and use of COVID‐19‐positive deceased organs;Pediatric Transplantation;2023-03-20

5. Bacterial and Viral Infection and Sepsis in Kidney Transplanted Patients;Biomedicines;2022-03-18